TY - JOUR
T1 - Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease
AU - for the NASH Clinical Research Network
AU - Vuppalanchi, Raj
AU - Siddiqui, Mohammad S.
AU - Van Natta, Mark L.
AU - Hallinan, Erin
AU - Brandman, Danielle
AU - Kowdley, Kris
AU - Neuschwander-Tetri, Brent A.
AU - Loomba, Rohit
AU - Dasarathy, Srinivas
AU - Abdelmalek, Manal
AU - Doo, Edward
AU - Tonascia, James A.
AU - Kleiner, David E.
AU - Sanyal, Arun J.
AU - Chalasani, Naga
N1 - Funding Information:
Supported by the National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713, to the Nonalcoholic Steatohepatitis Clinical Research Network), the National Center for Advancing Translational Sciences (UL1TR000439, UL1TR000077, UL1TR000436, UL1TR000150, UL1TR000424, UL1TR000006, UL1TR000448, UL1TR000040, UL1TR000100, UL1TR000004, UL1TR000423, UL1TR000058, UL1TR000454), and the Intramural Research Program of the National Institutes of Health, National Cancer Institute.
Publisher Copyright:
© 2017 by the American Association for the Study of Liver Diseases.
PY - 2018/1
Y1 - 2018/1
N2 - Vibration-controlled transient elastography estimates liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), which are noninvasive assessments of hepatic fibrosis and steatosis, respectively. However, prior vibration-controlled transient elastography studies reported high failure rates in patients with nonalcoholic fatty liver disease. We examined the performance characteristics of the FibroScan 502 Touch with two probes, medium (M+) and extra large (XL+), in patients with nonalcoholic fatty liver disease in a multicenter setting. A total of 1,696 exams were attempted in 992 patients (body mass index, 33.6 ± 6.5 kg/m2) with histologically confirmed nonalcoholic fatty liver disease. Simultaneous assessment of LSM and CAP was performed using the FibroScan 502 Touch with an automatic probe selection tool. Testing was conducted twice in patients by either a single operator (87%) or two operators (13%). Failure was defined as the inability to obtain a valid examination. An examination was considered unreliable if LSM interquartile range/median was >30%. Significant disagreement between two readings was defined as >95% limits of agreement between two readings. A total of 1,641 examinations yielded valid results with a failure rate of 3.2% (55/1,696). The proportion of unreliable scans for LSM was 3.9%. The proportion of unreliable scans with operator experience in the top quartile (≥59 procedures) was significantly lower than that in the lower three quarters combined (1.6% versus 4.7%, P = 0.02 by Fisher's exact test). The significant disagreement between first and second readings for LSM and CAP when obtained back to back was 18% and 11%, respectively. Conclusion: Vibration-controlled transient elastography for estimation of LSM and CAP can be successfully deployed in a multicenter setting with low failure (3.2%) and high reliability (>95%) rates and high reproducibility. (Hepatology 2018;67:134-144).
AB - Vibration-controlled transient elastography estimates liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), which are noninvasive assessments of hepatic fibrosis and steatosis, respectively. However, prior vibration-controlled transient elastography studies reported high failure rates in patients with nonalcoholic fatty liver disease. We examined the performance characteristics of the FibroScan 502 Touch with two probes, medium (M+) and extra large (XL+), in patients with nonalcoholic fatty liver disease in a multicenter setting. A total of 1,696 exams were attempted in 992 patients (body mass index, 33.6 ± 6.5 kg/m2) with histologically confirmed nonalcoholic fatty liver disease. Simultaneous assessment of LSM and CAP was performed using the FibroScan 502 Touch with an automatic probe selection tool. Testing was conducted twice in patients by either a single operator (87%) or two operators (13%). Failure was defined as the inability to obtain a valid examination. An examination was considered unreliable if LSM interquartile range/median was >30%. Significant disagreement between two readings was defined as >95% limits of agreement between two readings. A total of 1,641 examinations yielded valid results with a failure rate of 3.2% (55/1,696). The proportion of unreliable scans for LSM was 3.9%. The proportion of unreliable scans with operator experience in the top quartile (≥59 procedures) was significantly lower than that in the lower three quarters combined (1.6% versus 4.7%, P = 0.02 by Fisher's exact test). The significant disagreement between first and second readings for LSM and CAP when obtained back to back was 18% and 11%, respectively. Conclusion: Vibration-controlled transient elastography for estimation of LSM and CAP can be successfully deployed in a multicenter setting with low failure (3.2%) and high reliability (>95%) rates and high reproducibility. (Hepatology 2018;67:134-144).
UR - http://www.scopus.com/inward/record.url?scp=85038237482&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038237482&partnerID=8YFLogxK
U2 - 10.1002/hep.29489
DO - 10.1002/hep.29489
M3 - Article
C2 - 28859228
AN - SCOPUS:85038237482
SN - 0270-9139
VL - 67
SP - 134
EP - 144
JO - Hepatology
JF - Hepatology
IS - 1
ER -